We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Celadon Pharmaceuticals Plc | LSE:CEL | London | Ordinary Share | GB00BDQYGP38 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 16.00 | 14.00 | 18.00 | 16.00 | 14.80 | 16.00 | 8,093 | 08:00:03 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 149k | -7.14M | -0.1078 | -1.48 | 10.6M |
Hot Features
Premium
RNS Number:6014P
Celsis International PLC
10 September 2003
Celsis international plc
Interim Results Announcement Date
Celsis International plc, the rapid microbial testing company, will announce
Interim Results for the six months to 30th September 2003 on Wednesday 29th
October 2003.
There will be a presentation to analysts on the day at 11.00am, held at College
Hill, 78 Cannon Street, London, EC4N 6HH.
10 September 2003
ENQUIRIES:
College Hill Tel: 020 7457 2020
Nicholas Nelson
Corinna Dorward
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORGGGMLMGMGFZM
1 Year Celadon Pharmaceuticals Chart |
1 Month Celadon Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
